The Complication Rates of Oral Anticoagulation Therapy in Deep Venous Thrombosis
Open Access
- 1 September 2019
- journal article
- Published by Walter de Gruyter GmbH in Acta Medica Marisiensis
- Vol. 65 (3) , 87-90
Abstract
The objective of the current study is to evaluate the complication rates (embolic and hemorrhagic events) in deep venous thrombosis (DVT) patients on different types of oral anticoagulation therapy (OAC): direct oral anticoagulant therapy and vitamin K antagonist therapy. Methods: A number of 62 DVT patients were included and divided in two groups, depending on the type of oral anticoagulation therapy administered. The first group was composed of patients treated with direct oral anticoagulant treatment (Dabigatran, Rivaroxaban) and the second group was composed of patients treated with vitamin K antagonist (Acenocumarol). General data, including BMI and comorbidities were noted. Embolic and hemorrhagic events were noticed. Results : in the first group of patients (DOAC therapy), a number of 34 patients were included (14 of them with BMI higher than 25 kg/m2 and 14 with concomitant atrial fibrillation), while the second group comprised of 28 patients treated with VKA (21 of them with a high BMI and only 3 of them with atrial fibrillation). After a mean period of 36 months of anticoagulant therapy, complications were present in 17 patients, hematuria (8 episodes) and pulmonary embolism (4 cases) were the most frequent, with no difference regarding the treatment applied. Conclusion: No statistically significant difference was encountered regarding embolic and hemorrhagic event rates in our deep vein thrombosis patients.Keywords
This publication has 7 references indexed in Scilit:
- A Review of the Role of Non-Vitamin K Oral Anticoagulants in the Acute and Long-Term Treatment of Venous ThromboembolismCardiology and Therapy, 2018
- Deep vein thrombosisBMJ, 2018
- Antithrombotic Therapy for VTE DiseaseChest, 2016
- The ATLS® classification of hypovolaemic shock: A well established teaching tool on the edge?Injury, 2014
- Novel Oral Anticoagulants in Patients With Renal Insufficiency: A Meta-analysis of Randomized TrialsCanadian Journal of Cardiology, 2014
- Mechanisms of thrombosis in obesityCurrent Opinion in Hematology, 2013
- Value of assessment of pretest probability of deep-vein thrombosis in clinical managementThe Lancet, 1997